Osteorheumatology 2020

Click on title to open the video

· Introduction – Gerolamo Bianchi

· CRPS-I: diagnosis and treatment – Giuseppe Girasole

· Long term follow-up of the Bioreuma Project – Paola Diana

· Rare Bone Diseases: From Mutations to Treatments – Socrates Papapoulos

· Sarcopenia: diagnosis and treatment – Piet Geusens

· The role of subchondal bone in the pathogenesis of osteoarthritis – Steven Goldring

· Current approaches in the treatment of osteoarthritis – Xavier Chevalier

· Changing concepts for imaging in spondyloarthritis – Xenofon Baraliakos

· Patient profiling in the treatment of spondyloarthritis – Andrea Delle Sedie

· The concept of imminent risk of fracture – Christian Roux

· Bone forming agents in the treatment of osteoporosis – Serge Ferrari

· (Interleukin 17) inhibition – Carlo Selmi

· Management of RMD (Rheumatic Muscoloskeletal Diseases) patients in the post-Covid-19 era – Monica Pendolino

· Long-term management of Rheumatoid Arthritis with Jakinhibitors – Lorenzo Dagna

· Jak1-Jak2 Inhibition: real life data – Marica Doveri

· New small molecules on the horizon – Roberto Caporali

· IL-6 (interleukin 6) the master cytokine in Rheumatoid Arthritis? – Daniela Rossi

· Clinical management of GCA-PMR (giant cell arteritis-polymyalgia rheumatica) – Dario Camellino

· Regulation of bone loss in RA – Georg Schett

· Patient profiling in RA – Carl Goodyear

· The biosimilars era in rheumatology – Peter Taylor

· Glucocorticoids in Rheumatic Disease: 70th anniversary – Frank Buttgereit

· Glucocorticoid-inducedosteoporosis – Willem Lems

· Bisphosphonates and cardiovascular diseases – Andrea Giusti

Lecture

· The role of Interleukin 1 in patients with RA & type 2 diabetes – Marc Donath